戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 thelial cells, and neural cells derived from human embryonic stem cells.
2 ith the undifferentiated status of mouse and human embryonic stem cells.
3 nct developmental identities of mouse versus human embryonic stem cells.
4 cts transcriptional silencing of INK4-ARF in human embryonic stem cells.
5 the appropriate telomere length set point in human embryonic stem cells.
6  chromatin hallmarks of a bivalent domain in human embryonic stem cells.
7 rly human pre-implantation embryos and naive human embryonic stem cells.
8 n mesendodermal differentiation of mouse and human embryonic stem cells.
9  by mapping the m(6)A methylome in mouse and human embryonic stem cells.
10 ces to directed, in vitro differentiation of human embryonic stem cells.
11 ency by repressing let-7 miRNA expression in human embryonic stem cells.
12 ring pancreatic endocrine differentiation of human embryonic stem cells.
13 e regeneration in place of the controversial human embryonic stem cells.
14 ctivities during in vitro differentiation of human embryonic stem cells.
15  applied it to analyze a ChIP-seq dataset in human embryonic stem cells.
16 adeno-associated virus integration site 1 in human embryonic stem cells.
17             Similar results were obtained in human embryonic stem cells.
18 rdiac mesoderm formation in frog embryos and human embryonic stem cells.
19 e developmental and pluripotent potential of human embryonic stem cells.
20 olyamides to genomes directly within live H1 human embryonic stem cells.
21 es bound by Polycomb repressive complex 2 in human embryonic stem cells.
22 rom the ethical issues or immune barriers of human embryonic stem cells.
23 ntial for actinomycin-D-induced apoptosis in human embryonic stem cells.
24 n glycosphingolipids previously described in human embryonic stem cells, a number of type 2 core chai
25                   Pseudotemporal ordering of human embryonic stem cell and induced pluripotent stem c
26 logy development, applications of IDP-ASE to human embryonic stem cells and breast cancer cells indic
27                                              Human embryonic stem cells and especially patient specif
28                   We test our approach on H1 human embryonic stem cells and H1-derived neural progeni
29                                     VPs from human embryonic stem cells and hiPSCs were generated wit
30         This approach works efficiently with human embryonic stem cells and human induced pluripotent
31 uripotent stem cells (hPSCs), including both human embryonic stem cells and human-induced pluripotent
32  authors show that ablation of PRC2 genes in human embryonic stem cells and in mice results in change
33 eded to maintain stem cell cultures, so that human embryonic stem cells and induced pluripotent stem
34 an pluripotent stem cells (hPSCs), including human embryonic stem cells and induced pluripotent stem
35                                     Although human embryonic stem cells and induced pluripotent stem
36 robust EHTs from cardiomyocytes derived from human embryonic stem cells and induced pluripotent stem
37 poietic emergence from hPSCs, including both human embryonic stem cells and inducible pluripotent ste
38     We defined a Smad2 regulatory circuit in human embryonic stem cells and mouse epiblast stem cells
39                                              Human embryonic stem cells and mouse epiblast stem cells
40 1R interacts with and phosphorylates PCNA in human embryonic stem cells and other cell lines.
41 implementing protein-based genome editing in human embryonic stem cells and primary cells.
42 2015) derive oligodendrocyte precursors from human embryonic stem cells and show that engrafted cells
43 ANOG, at levels similar to those measured in human embryonic stem cells and to acquire a plastic stat
44 ssion of a single copy of the mutant SOD1 in human embryonic stem cells and were prevented by genetic
45 d it to interrogate the 2-Mb POU5F1 locus in human embryonic stem cells, and identified 45 cis-regula
46                                         Only human embryonic stem cell- and CB-iPSC-derived VPs relia
47 describe a micropatterning approach in which human embryonic stem cells are confined to disk-shaped,
48 mplex 2 is dispensable for pluripotency when human embryonic stem cells are converted into the naive
49  mark at the promoter regions in pluripotent human embryonic stem cells, are essentially devoid of DN
50                            The generation of human embryonic stem cell banking networks has ensured t
51  OCT4-targeting guide RNA using an inducible human embryonic stem cell-based system and microinjectio
52 capability, there are great expectations for human embryonic stem cells, both as a resource for funct
53  definitive endoderm (DE) differentiation of human embryonic stem cells by attenuating the duration o
54  In this issue, Chung et al. (2014) generate human embryonic stem cells by fusing an adult somatic ce
55                          Here we report that human embryonic stem cells can be induced to differentia
56  NPCs from embryonic kidneys or derived from human embryonic stem cells can be propagated.
57 et al. (2016) show that a confined colony of human embryonic stem cells can spontaneously sense its b
58 ut of polycomb repressive complex 2 genes in human embryonic stem cells causes pluripotency loss and
59         Luciferase transgene-marked VPs from human embryonic stem cells, CB-iPSCs, and fibroblast-iPS
60 d a system using neurons differentiated from human embryonic stem cells, cultured in microfluidic dev
61 f EZH2 in embryonic pancreas explants and in human embryonic stem cell cultures increased endocrine p
62 implantation blastocysts, and ceasing during human embryonic stem cell derivation from blastocyst out
63 r small RNAs in VZV-infected fibroblasts and human embryonic stem cell-derived (hESC) neurons.
64 e molecular signatures in 1-year (y) matured human embryonic stem cell-derived cardiomyocytes (hESC-C
65                                              Human embryonic stem cell-derived cardiomyocytes (hESC-C
66                                              Human embryonic stem cell-derived cardiomyocytes (hESC-C
67        We found that suppression of PRRX1 in human embryonic stem cell-derived cardiomyocytes and emb
68                     We constructed EHMs from human embryonic stem cell-derived cardiomyocytes and rel
69                             Additionally, in human embryonic stem cell-derived cardiomyocytes challen
70 cts, consistent with patch-clamp studies, on human embryonic stem cell-derived cardiomyocytes hESC-CM
71 art muscles (EHMs) were generated by casting human embryonic stem cell-derived cardiomyocytes with co
72 IKV infection leads to microcephaly, we used human embryonic stem cell-derived cerebral organoids to
73  selective for NSCs than mature neurons in a human embryonic stem cell-derived culture containing a m
74 enerated mouse monoclonal antibodies against human embryonic stem cell-derived definitive endoderm wi
75                                              Human embryonic stem cell-derived endothelial cells (hES
76                                              Human embryonic stem cell-derived endothelial cells (hES
77                                        Using human embryonic stem cell-derived intestinal organoids,
78       Here, we analyze the transcriptomes of human embryonic stem cell-derived lineage-specific proge
79 uring TGF-beta-induced SM differentiation of human embryonic stem cell-derived mesenchymal cells.
80 yonic neural progenitor cells in vivo and on human embryonic stem cell-derived neural progenitors.
81 pecifically activated following infection of human embryonic stem cell-derived neurons and that this
82                                        Using human embryonic stem cell-derived NPCs to model neurogen
83 of 1776 cells by scRNA-seq covering distinct human embryonic stem cell-derived progenitor states.
84 modified mRNA transfection can be applied to human embryonic stem cell-derived RPE cells and that the
85   We therefore evaluated TVM expression in a human embryonic stem cell-derived teratoma (hESCT) tumor
86 t primary sporadic ALS (sALS) astrocytes and human embryonic stem-cell-derived MNs.
87                                   Studies of human embryonic-stem-cell-derived cardiomyocytes (hESC-C
88 y pathways block the rejection of xenogeneic human embryonic-stem-cell-derived pancreatic endoderm (h
89 e the transcriptome of distal projections of human embryonic stem cells differentiated using a protoc
90 ets and identify key kinases associated with human embryonic stem cell differentiation and insulin si
91 gnalling effectors, and the epigenome during human embryonic stem cell differentiation.
92 ological contexts: yeast stress response and human embryonic stem cell differentiation.
93 d this strategy to isolate hPSCs (hiPSCs and human embryonic stem cells) during routine culture and s
94 sformed lymphoblastoid cell lines (LCLs) and human embryonic stem cell (ES) lines, but were not signi
95 s the generation of isogenic FANCA-deficient human embryonic stem cell (ESC) lines.
96                                    Our novel human embryonic stem cell (ESC)-based model yields high
97 ood, Rafii et al present an elegant study of human embryonic stem cell (ESC)-derived hematopoiesis in
98  we produced RNA-genome interaction maps for human embryonic stem cells (ESCs) and human embryonic ki
99 ient generation of hypothalamic neurons from human embryonic stem cells (ESCs) and induced pluripoten
100 thylation are not intrinsically different in human embryonic stem cells (ESCs) and induced pluripoten
101 a system for precise genetic modification of human embryonic stem cells (ESCs) and induced pluripoten
102 ntiation of forebrain GABA interneurons from human embryonic stem cells (ESCs) and induced pluripoten
103        Available methods for differentiating human embryonic stem cells (ESCs) and induced pluripoten
104             We have recently derived haploid human embryonic stem cells (ESCs) by parthenogenesis and
105 inal organoids (HIOs) produced in vitro from human embryonic stem cells (ESCs) or induced pluripotent
106      Whether neurons generated in vitro from human embryonic stem cells (ESCs) or induced pluripotent
107 lly active DNA methyltransferases (DNMTs) in human embryonic stem cells (ESCs) using CRISPR/Cas9 geno
108 ancers identified by chromatin signatures in human embryonic stem cells (ESCs), capture 77% of RNA po
109 We compare nucleosome occupancy in mouse and human embryonic stem cells (ESCs), induced-pluripotent s
110 ort on the generation of a human WS model in human embryonic stem cells (ESCs).
111 g in embryonic fibroblasts, macrophages, and human embryonic stem cells (ESCs).
112 tegration of human imaging reporter genes in human embryonic stem cells for long-term molecular imagi
113 ted by in vitro neural differentiation of FX human embryonic stem cells (FX-hESCs), derived from FXS
114 mino)ethyl acrylate, which support long-term human embryonic stem cell growth and pluripotency over a
115                                Studies using human embryonic stem cells have revealed how common canc
116  by excitatory cortical neurons derived from human embryonic stem cells (hECNs).
117 regulated in the hemogenic population during human embryonic stem cell hematopoietic differentiation
118 ein-coding genes (exomes) of 140 independent human embryonic stem cell (hES cell) lines, including 26
119 This two-step strategy was used to establish human embryonic stem cell (hESC) and induced pluripotent
120 eeding on CPC for bone regeneration, and (5) human embryonic stem cell (hESC) and induced pluripotent
121 the mechanisms which govern the formation of human embryonic stem cell (hESC) colonies.
122              The extremely low efficiency of human embryonic stem cell (hESC) derivation using somati
123                           The application of human embryonic stem cell (hESC) derivatives to regenera
124 ed splicing (epi)genetic code, DeepCode, for human embryonic stem cell (hESC) differentiation by inte
125 arrays to identify epigenetic changes during human embryonic stem cell (hESC) differentiation.
126 e established several human stem cell lines: human embryonic stem cell (hESC) line carrying the commo
127 ted from a large number (1 x 10(9) cells) of human embryonic stem cell (hESC) lines allowed identific
128 e undertaken a transcriptional comparison of human embryonic stem cell (hESC) lines and hiPSC lines a
129                   Here, we report engineered human embryonic stem cell (hESC) lines for modeling thes
130          To test this directly, we generated human embryonic stem cell (hESC) lines where both allele
131 s and different delivery systems, as well as human embryonic stem cell (hESC) lines.
132                                    We used a human embryonic stem cell (hESC) model that recapitulate
133 f-renewing perivascular progenitors from the human embryonic stem cell (hESC), line ESI-017.
134 n chromosome 10) during neurite outgrowth of human embryonic stem cell (hESC)-derived neuronal progen
135             We used epigenomic annotation in human embryonic stem cell (hESC)-derived pancreatic prog
136 xpression analysis of >30 batches of grafted human embryonic stem cell (hESC)-derived progenitors.
137                   Using neurons derived from human embryonic stem cells (hESC) and cell-free wild-typ
138                                              Human embryonic stem cells (hESC) and induced pluripoten
139                       We differentiated hes2 human embryonic stem cells (hESC) and Macaca nemestrina-
140           Here, we evaluated the survival of human embryonic stem cells (hESC) constitutively express
141                               Differentiated human embryonic stem cells (hESC) continue to provide a
142 ional (3D) neuronal cell models derived from human embryonic stem cells (hESC) provide an excellent t
143 rm to long-term safety of cells derived from human embryonic stem cells (hESC) transplanted into pati
144 in conformations in the nucleoli of iPSC and human embryonic stem cells (hESC) were found to be simil
145 ds used to differentiate and purify RPE from human embryonic stem cells (HESC), and describe the surg
146 rated the monoclonal antibody mAb-A4 against human embryonic stem cells (hESC), which also bound spec
147 ZHY enhanced hepatocyte differentiation from human embryonic stem cells (hESC).
148  GSK-3beta is itself modified by O-GlcNAc in human embryonic stem cells (hESC).
149 her transplanted MGE-like cells derived from human embryonic stem cells (hESC-MGEs) can mitigate the
150 l models of SDS through knockdown of SBDS in human embryonic stem cells (hESCs) and generation of ind
151          We then found CX45 was expressed in human embryonic stem cells (hESCs) and human dermal fibr
152                            We show here that human embryonic stem cells (hESCs) and human induced plu
153 fficient generation of striatal neurons from human embryonic stem cells (hESCs) and induced pluripote
154  fundamental to the activity and behavior of human embryonic stem cells (hESCs) and induced pluripote
155                            In order to apply human embryonic stem cells (hESCs) and induced pluripote
156 how that a sub-population within cultures of human embryonic stem cells (hESCs) and induced pluripote
157 steogenic progenitor cells derived from both human embryonic stem cells (hESCs) and induced pluripote
158 e demonstrated ability to differentiate both human embryonic stem cells (hESCs) and patient-derived i
159 metabolism changes during differentiation of human embryonic stem cells (hESCs) and reprogramming of
160                                              Human embryonic stem cells (hESCs) are a potential resou
161          Pancreatic progenitors derived from human embryonic stem cells (hESCs) are a potential sourc
162                                              Human embryonic stem cells (hESCs) are highly sensitive
163                                              Human embryonic stem cells (hESCs) are pluripotent cells
164                                              Human embryonic stem cells (hESCs) are used as platforms
165                                        Naive human embryonic stem cells (hESCs) can be derived from p
166    Under defined differentiation conditions, human embryonic stem cells (hESCs) can be directed towar
167                                              Human embryonic stem cells (hESCs) can be efficiently an
168                                              Human embryonic stem cells (hESCs) can be induced and di
169                                              Human embryonic stem cells (hESCs) can generate the thre
170     Furthermore, replication profiles of FXS human embryonic stem cells (hESCs) compared to nonaffect
171                                              Human embryonic stem cells (hESCs) differentiate into fu
172                    Activin/SMAD signaling in human embryonic stem cells (hESCs) ensures NANOG express
173 at TET1, TET2 and TET3 triple-knockout (TKO) human embryonic stem cells (hESCs) exhibit prominent biv
174                                   The use of human embryonic stem cells (hESCs) for regenerative medi
175 nts in the human embryo, we used colonies of human embryonic stem cells (hESCs) grown on micropattern
176            Dissociation-induced apoptosis of human embryonic stem cells (hESCs) hampers their large-s
177         While the transcriptional network of human embryonic stem cells (hESCs) has been extensively
178 tors or insulin-secreting cells derived from human embryonic stem cells (hESCs) has been proposed as
179                                              Human embryonic stem cells (hESCs) have been routinely t
180                                              Human embryonic stem cells (hESCs) have the capacity to
181  induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) have the capacity to
182                                              Human embryonic stem cells (hESCs) hold great promise fo
183 role of the WNT receptor FZD7 in maintaining human embryonic stem cells (hESCs) in an undifferentiate
184 n interactions and target gene expression in human embryonic stem cells (hESCs) in response to early
185 vo and influence differentiation outcomes in human embryonic stem cells (hESCs) in vitro Systematic i
186            The differentiation efficiency of human embryonic stem cells (hESCs) into heart muscle cel
187 determinants regulating the specification of human embryonic stem cells (hESCs) into hematopoietic ce
188 mics occurring during the differentiation of human embryonic stem cells (HESCs) into the erythroid li
189 in vitro method to direct differentiation of human embryonic stem cells (hESCs) into thymic epithelia
190                                              Human embryonic stem cells (hESCs) is a potential unlimi
191           In vitro neural differentiation of human embryonic stem cells (hESCs) is an advantageous sy
192     Maintenance of the self-renewal state in human embryonic stem cells (hESCs) is the foremost criti
193 ) cells in spin embryoid bodies derived from human embryonic stem cells (hESCs) lack HOXA expression
194 re concurrently overexpressed in transformed human embryonic stem cells (hESCs) or hESCs cultured in
195  colonic organoids (COs) from differentiated human embryonic stem cells (hESCs) or induced pluripoten
196                    Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited
197                           Differentiation of human embryonic stem cells (hESCs) provides a unique opp
198  induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) remains controversial
199                                              Human embryonic stem cells (hESCs) represent an unlimite
200 ime the properties of neurons developed from human embryonic stem cells (hESCs) that carry the FMR1 m
201  this study we investigated the potential of human embryonic stem cells (hESCs) to differentiate into
202                               The ability of human embryonic stem cells (hESCs) to differentiate into
203                                      We used human embryonic stem cells (hESCs) to examine whether me
204 re, we use both developing mouse embryos and human embryonic stem cells (hESCs) to explore the mechan
205 es in the 26-day directed differentiation of human embryonic stem cells (hESCs) to insulin-positive c
206                                 Here, we use human embryonic stem cells (hESCs) to show that the Acti
207 anslational modifications and p53 binding in human embryonic stem cells (hESCs) undergoing differenti
208                      To model hematopoiesis, human embryonic stem cells (hESCs) were allowed to diffe
209 rofiles that are differentially changed when human embryonic stem cells (hESCs) were differentiated t
210                              Until recently, human embryonic stem cells (hESCs) were shown to exist i
211 ly in cells undergoing reprogramming but not human embryonic stem cells (hESCs), and inhibiting TRAIL
212                                           In human embryonic stem cells (hESCs), bivalent genes with
213 fferentiation, we quantified the proteome of human embryonic stem cells (hESCs), cardiac progenitor c
214 ed the epigenetic status of undifferentiated human embryonic stem cells (hESCs), hESC-derived early e
215                                           In human embryonic stem cells (hESCs), MLL-AF4 skewed hemat
216  dynamics during directed differentiation of human embryonic stem cells (hESCs), we identified a supp
217 s are reproduced by expressing mutant FUS in human embryonic stem cells (hESCs), whereas knockdown of
218                 This origin is absent in FXS human embryonic stem cells (hESCs), which have the SNP v
219                                           In human embryonic stem cells (hESCs), Wnt/beta-catenin sig
220                                              Human embryonic stem cells (hESCs)-derived keratinocytes
221 ic dopaminergic (mesDA) neurons derived from human embryonic stem cells (hESCs).
222 ferentiation process in adherent colonies of human embryonic stem cells (hESCs).
223 h pluripotency and neural differentiation of human embryonic stem cells (hESCs).
224 r homogeneous hEB formation from dissociated human embryonic stem cells (hESCs).
225 ompassing cerebral cortical development from human embryonic stem cells (hESCs).
226 nerate a high-confidence isoform dataset for human embryonic stem cells (hESCs).
227 B) as an essential factor in self-renewal of human embryonic stem cells (hESCs).
228 l hepatocyte-like cells (hepatic cells) from human embryonic stem cells (hESCs).
229 ith beta-catenin to Wnt response elements in human embryonic stem cells (hESCs).
230 K) signaling, which plays important roles in human embryonic stem cells (hESCs).
231 poietic progenitor cells (HPCs) derived from human embryonic stem cells (hESCs).
232  and mid/hindbrain cell differentiation from human embryonic stem cells (hESCs).
233 y sequences within the 1-Mbp POU5F1 locus in human embryonic stem cells (hESCs).
234 is required for self-renewal and survival of human embryonic stem cells (hESCs).
235 ORC1 pathway in several cell types including human embryonic stem cells (hESCs).
236  induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs).
237  in GSL expression during differentiation of human embryonic stem cells; however, little is known abo
238 gize to induce endodermal differentiation of human embryonic stem cells; however, the underlying mech
239 ed to levitate neuroprogenitors derived from human embryonic stem cells in 3D multilayered fibrin tis
240 onserved, as shown by the differentiation of human embryonic stem cells in a model of human pancreas
241 pecific methylated or unmethylated motifs in human embryonic stem cells in vivo.
242                Thus, the glycan diversity of human embryonic stem cells, including cell surface immun
243 were induced early during differentiation of human embryonic stem cells into cardiomyocytes.
244                            However, to bring human embryonic stem cells into clinical applications, t
245 tly reported the in vitro differentiation of human embryonic stem cells into insulin-secreting cells,
246 ave reassessed this issue by differentiating human embryonic stem cells into melanocytes.
247  of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural prog
248 raftment of cardiac progenitors derived from human embryonic stem cells into patients is now feasible
249 ly controlled gene regulation in 3D-cultured human embryonic stem cells is developed using hollow gol
250           Both hPAP and normal iPS cells had human embryonic stem cell-like morphology, expressed plu
251 predicted to be Enhancers specific to the H1 human embryonic stem cell line (H1-hESC).
252 h an EFNB2-tdTomato/EPHB4-EGFP dual reporter human embryonic stem cell line to identify factors that
253 produced by an 80% RUNX1 knockdown in the H9 human embryonic stem cell line, and a genomic instabilit
254 bitor of CARM1-mediated H3R17 methylation in human embryonic stem cell line, we find that H3R17 methy
255 ll stages derived from a HES5::eGFP reporter human embryonic stem cell line.
256 IL-34 in dopaminergic neurons derived from a human embryonic stem cell line.
257 c bisulfite sequencing performed on the same human embryonic stem cell line.
258 lineage allocation in humans, we derived ten human embryonic stem cell lines (designated UCSFB1-10) f
259 target five genes in three hPSC lines: three human embryonic stem cell lines, neural progenitors and
260 pid, has been commonly used as a pluripotent human embryonic stem cell marker, and its expression is
261                           In the nucleoli of human embryonic stem cells, methylated LIN28A sequesters
262              Here we show, using an isogenic human embryonic stem cell model of RTT, that MECP2 mutan
263 ed protocols for directed differentiation of human embryonic stem cells, obtaining efficient, acceler
264  transplantable insulin-producing cells from human embryonic stem cells or induced pluripotent stem c
265 rogenitor cells (hGPCs), derived from either human embryonic stem cells or mHTT-transduced fetal hGPC
266 onic pathways related to cell proliferation, human embryonic stem cell pluripotency, tissue regenerat
267 ntestinal and metabolic tissues derived from human embryonic stem cells, populated by gut microbiota.
268                                              Human embryonic stem cells progress through multiple sta
269 sive mature beta cells that are derived from human embryonic stem cells (referred to as SC-beta cells
270        This allowed us to use the RUNX1C-GFP human embryonic stem cell reporter cell line to monitor
271 uman cortical interneurons in an NKX2.1::GFP human embryonic stem cell reporter line.
272 ded to federal funding limitations placed on human embryonic stem cell research and the potential of
273 tion in neural progenitor cells derived from human embryonic stem cells, resulting in neoplastic tran
274     Now, modern genome-editing techniques in human embryonic stem cells reveal TPP1 as the essential
275 ng pancreatic and hepatic differentiation of human embryonic stem cells revealed the en masse acquisi
276                                        Using human embryonic stem cell SELEX-Seq data, MPBind achieve
277 ll, Wang et al. find that linc-RoR maintains human embryonic stem cell self-renewal by functioning as
278                   Extensive validation using human embryonic stem cells showed high consistency betwe
279 ructs built with cardiomyocytes derived from human embryonic stem cells, simultaneous optical and ele
280           Formative research suggests that a human embryonic stem cell-specific alternative splicing
281                               Here, we use a human embryonic stem cell system to model this tumor.
282 ngle cells in a population of methanol-fixed human embryonic stem cells, the histogram of corrected 7
283 repressive complex 2 (PRC2) binding sites in human embryonic stem cells, thereby phenocopying a more
284  can be efficiently generated from mouse and human embryonic stem cells through manipulation of the t
285 lling pathways, we develop a method to guide human embryonic stem cells to a near-pure population (>9
286                                      We used human embryonic stem cells to explore how these pathways
287 ional design of differentiation protocols of human embryonic stem cells to specific cell types for di
288                 Here, we use differentiating human embryonic stem cells to study the role of BRA in a
289 riptional data across the differentiation of human embryonic stem cells to the three germ layers.
290 BAergic interneuron progenitors derived from human embryonic stem cells to treat chronic temporal lob
291 ract enhancer signatures in a representative human embryonic stem cell type (H1) and a differentiated
292                                  Cultures of human embryonic stem cell typically rely on protein matr
293 ned expression signatures more comparable to human embryonic stem cell VPs, expressed higher levels o
294 K293T, human primary neonatal fibroblast and human embryonic stem cells was increased dramatically re
295                                           In human embryonic stem cells, we find that the dCas9 effec
296                  Using genome engineering of human embryonic stem cells, which have physiological tel
297              Gain-of-function experiments in human embryonic stem cells, which normally lack lncRHOXF
298                                          The human embryonic stem cells whole-cell SELEX-Seq data are
299                                    Moreover, human embryonic stem cells with deletion of EZH1 or EZH2
300 P-RNAPII (RNA polymerase II) at promoters in human embryonic stem cells, with a minor peak in the ter

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top